Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

InVivo Therapeutics Holdings Corp

+ Add to Watchlist

O4I:GR

3.049 EUR 0.301 10.95%

As of 11:17:33 ET on 03/31/2015.

Snapshot for InVivo Therapeutics Holdings Corp (O4I)

Open: 2.495 Day's Range: 2.495 - 3.049 Volume: 1,000
Previous Close: 2.748 52wk Range: 0.341 - 3.049 1-Yr Rtn: +174.19%

Stock Chart for O4I

No chart data available.
  • O4I:GR 3.049
  • 1D
  • 1M
  • 1Y
2.748
Interactive O4I Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for O4I

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M EUR) 312.25
Shares Outstanding (M) 102.41
30 Day Average Volume 578
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for O4I

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for O4I

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company. The Company is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.

Mark D PerrinChief Executive OfficerSteven McAllister "Steve"Chief Financial Officer
Lorianne K MasuokaChief Medical OfficerThomas R UlichChief Scientific Officer
More Company Profile & Key Executives for O4I

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil